肿瘤细胞凋亡因子激素肽；Tcapf/2120397-85-3/Nerofe

Product Name：Nerofe

CAS No.：2120397-85-3

Synonyms：肿瘤细胞凋亡因子激素肽；Tcapf

Catalog No.：218P422

Brand：Typeptide Biotech（肽研生物）

Description：Nerofe是一种合成的14个氨基酸的肽，多肽序列中含有13个D型的氨基酸，来源于一种新型的人类肽类激素——肿瘤细胞细胞凋亡因子（TCApF），具有潜在的抗肿瘤活性。作为药物使用时，静脉给药后，Nerofe与T1/ST2受体（IL1RL1）结合，并激活caspase 8和Bcl-2介导的细胞凋亡，此外还激活肿瘤细胞中p38 MAPK和JNK信号级联。此外，该制剂通过抑制血管内皮生长因子A（VEGFA）和fms相关酪氨酸激酶1（VEGFR1）的表达来抑制血管生成。Nerofe也通过增加白介素-10和抗血管生成白介素的表达来调节免疫系统反应。T1/ST2受体是toll/白细胞介素-1受体超家族的成员，在某些癌症细胞中过表达。本公司生产的Nerofe属于研发级多肽。

Nerofe is a synthetic peptide of 14 amino acids, containing 13 D-type amino acids in its peptide sequence. It is derived from a novel human peptide hormone, tumor cell apoptosis factor (TCApF), and has potential anti-tumor activity. When used as a drug, after intravenous administration, Nerofe binds to the T1/ST2 receptor (IL1RL1) and activates caspase 8 and Bcl-2 mediated cell apoptosis. In addition, it also activates the p38 MAPK and JNK signaling cascades in tumor cells. In addition, the formulation inhibits angiogenesis by suppressing the expression of vascular endothelial growth factor A (VEGFA) and fms related tyrosine kinase 1 (VEGFR1). Nerofe also regulates the immune system response by increasing the expression of interleukin-10 and anti angiogenic interleukin. T1/ST2 receptors are members of the toll/interleukin-1 receptor superfamily and are overexpressed in certain cancer cells. The Nerofe produced by our company is a research and development grade peptide.

Purity (HPLC) ≥98.0%

Single impurity≤2%

Peptide content≥75.0%

Amino Acid Composition≤±15%

Bacterial Endotoxins≤50EU/mg

Solubility：H₂O/DMSO

Vacuum-packed with aluminum foil bag or transparent bag.Various weights can be packed according to your requirements.

Storage:Cool dry place( Store at -20°C, away from the light)

Remark:For Research Use Only. Not for human use.

订购联系方式：

南京肽研生物生物科技有限公司

手机号：19961912513(微信同号)

QQ: 2178255659

邮箱：sales@typeptide.com

联系人：顾经理

申明：本产品仅供科研使用，不得用于人体。